Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding [Phase 3]

View source ↗

Summary

Phase III study evaluating ilaprazole sodium for injection in preventing stress ulcer bleeding has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ilaprazole sodium for injection (ilaprazole sodium for injection)

Snippet

Sponsor: Livzon Pharmaceutical Group Inc. | Conditions: Stress Ulcer Bleeding | Phase 3 | Status: COMPLETED